Skip to main content

EASD 2023

ONWARDS 6: Weekly insulin icodec noninferior to daily degludec in type 1 diabetes

Weekly insulin icodec is noninferior to once-daily insulin degludec in people with type 1 diabetes, indicate findings from the ONWARDS 6 trial.

Tirzepatide enhances anti-obesity effects of intensive lifestyle intervention

27-10-2023 Obesity News

SURMOUNT-3 results indicate tirzepatide can enhance the weight loss achieved following an intensive lifestyle intervention.

Faster aspart feasible for pregnant and breastfeeding women with diabetes

12-10-2023 Diabetes and Pregnancy News

The insulin analog faster aspart is a viable alternative to insulin aspart as a treatment for pregnant and breastfeeding women with type 1 and type 2 diabetes.

SURPASS-6: Tirzepatide add-on boosts type 2 diabetes control

09-10-2023 Type 2 Diabetes News

The SURPASS-6 findings support the addition of tirzepatide to basal insulin for people with poorly controlled type 2 diabetes, demonstrating significant improvements in mean glycated hemoglobin and other benefits compared with use of adjunct insulin lispro.

Unlock your free access to coverage of the 2023 EASD Annual Meeting

More attention needed for depression in complicated diabetes

11-10-2023 Type 2 Diabetes News

Diabetes increases the risk of development of depressive symptoms, with this study finding a significant linear relationship between diabetes severity and risk of depression.

Insulin production maintained longer with antiviral medication

10-10-2023 Type 1 Diabetes News

A new phase 2 study shows that the insulin-producing function of beta cells is preserved for longer periods of time in people with newly diagnosed type 1 diabetes who are treated with antivirals pleconaril and ribavirin.

Three years of real-world data with GLP-1 receptor agonist semaglutide

10-10-2023 Type 2 Diabetes News

Real-world data from 23,442 patients taking weekly semaglutide injections shows improvement in weight and HbA1c levels over a 3-year period, with more pronounced results in patients with greater adherence to treatment.

Increased risk of cardiovascular death in adults with low muscle mass

Low muscle mass increases risk of all-cause mortality in people with diabetes, with double the risk for cardiovascular-disease-related deaths compared to those with normal muscle mass.

High risk of chronic kidney disease after gestational diabetes

11-10-2023 Gestational Diabetes News

Women who have experienced gestational diabetes have a higher risk of developing chronic kidney disease, with an increased risk of 92% compared to women without GDM.

Real-world study shows reduction in microvascular complications with SGLT2 inhibitors and GLP1 receptor agonists

10-10-2023 Type 2 Diabetes News

Both SGLT2 inhibitors and GLP-1 receptor agonists have been shown to lower the risk of microvascular complications over a 5-year period in people with type 2 diabetes, according to a large retrospective cohort analysis.

Higher mortality rate after heart attack in type 1 diabetes

10-10-2023 Type 1 Diabetes News

In the past 15 years, mortality rates after a first heart attack have dropped significantly for people with type 2 diabetes but this is not the case for people with type 1 diabetes.

Myocardial infarction and heart failure in young patients with type 2 diabetes

11-10-2023 Type 2 Diabetes News

Adolescents and young adults with type 2 diabetes have a higher risk of myocardial infarction and heart failure compared to their peers with type 1 diabetes.

Stay up to date with more from Springer Medicine

Guidelines for the management of cardiovascular disease in patients with diabetes

Watch the official ESC video recording of the presentation of the international guideline for prevention and management of CVD in patients with diabetes.

Overcoming clinical inertia in type 2 diabetes (Link opens in a new window)

Discussion-based webcast addressing the causes of clinical inertia in type 2 diabetes.

CME: 1.0 AMA PRA Category 1 Credit(s)™

Supported by:
  • Lilly

Episode 3: Unravelling resistant hypertension

Resistant hypertension is a difficult to treat and often misunderstood phenomenon that continues to frustrate cardiologists. In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options.

» Listen now

Prof. Morris Brown
Prof. Bryan Williams

Further Reading

Dietary management of diabetes

Nutrition Guideline

New evidence-based European guidelines provide strengthened and expanded recommendations on dietary management of type 2 diabetes, including dietary patterns, environmental sustainability, food processing, and patient support.

Rethinking the Impact and Management of Diabetes in Heart Failure Patients

Open Access Heart Failure

The presence of diabetes mellitus (DM) represents a significant risk factor for the development of heart failure (HF). Individuals with DM are approximately 2–5 times more likely to develop heart failure at a younger age [ 1 ]. Clinical studies …

Metabolically ‘extremely unhealthy’ obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study

Open Access Diabetes Original Paper

During the last decades, cardiovascular disease (CVD) risk is increased in obese patients with diabetes mellitus (DM) [ 1 ]. However, nowadays, there is an increasing prevalence of type 2 DM (T2DM) with lean/normal body mass index (BMI), which was …

A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective

Open Access Diabetes Therapy Review

People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps communicate with each other and how the …